vTv Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of vTv Therapeutics generated cash of -$19,081,000, which is less than the previous year. Cash used in financing activities reached the amount of $11,997,000 last year. Net change in cash is therefore -$2,680,000.
Cash Flow
| 2014 | -30.77M | 161K | 30.91M |
|---|---|---|---|
| 2015 | -36.94M | -79K | 123.64M |
| 2016 | -48.20M | -83K | 11.79M |
| 2017 | -44.56M | -25K | 7.5M |
| 2018 | -26.85M | 7K | 16.61M |
| 2019 | -23.01M | 242K | 22.87M |
| 2020 | -18M | 0 | 19.47M |
| 2021 | -19.30M | 0 | 26.97M |
| 2022 | -16.02M | -21K | 14.75M |
| 2023 | -19.08M | 4.40M | 11.99M |
VTVT Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 12.12M | 13.41M | 5.74M | 4.27M | 4.18M | 14.42M | 51.50M | 88.00M | 1.38M | 1.08M |
Operating activities | ||||||||||
Net income | -20.25M | -25.07M | -17.73M | -12.80M | -21.93M | -23.84M | -54.64M | -55.35M | -41.10M | -36.10M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 90K | 92K | 89K | 94K | 39K | 218K | 197K | 265K | 501K | 864K |
Stock-based compensation expense | 1.57M | 1.27M | 2.35M | 1.00M | 1.51M | 0 | 3.64M | 2.64M | 859K | 0 |
| Deferred income tax benefit | 1.57M | 1.27M | 2.35M | 1.00M | 1.51M | 0 | 3.64M | 2.64M | 859K | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 71K | -116K | 101K | -153K | -5K | 8M | -8M | 69K | -69K | -733K |
Inventories | 0 | 0 | -889K | -1.97M | 618K | 0 | 194K | -359K | 547K | 0 |
Accounts payable | 2.92M | -856K | 1.82M | -997K | -618K | -6.19M | 2.44M | 4.78M | 2.93M | 0 |
Cash generated by operating activities | -19.08M | -16.02M | -19.30M | -18M | -23.01M | -26.85M | -44.56M | -48.20M | -36.94M | -30.77M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -21K | 0 | 0 | -70K | -5K | -57K | -87K | -104K | -33K |
Acquisitions Net | 4.40M | 0 | 0 | 0 | 312K | 12K | 32K | 4K | 25K | -140K |
Cash generated by investing activities | 4.40M | -21K | 0 | 0 | 242K | 7K | -25K | -83K | -79K | 161K |
Financing activities | ||||||||||
Common Stock Issued | 12.03M | 14.78M | 26.75M | 24.42M | 32.94M | 21.5M | 0 | 0 | 105.77M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 302K | 923K | 0 | -2.5M |
Repayments of term debt | -33K | -32K | -715K | -5.45M | -10.07M | -5.38M | 7.5M | -11.79M | 19.28M | -148K |
Cash used in financing activities | 11.99M | 14.75M | 26.97M | 19.47M | 22.87M | 16.61M | 7.5M | 11.79M | 123.64M | 30.91M |
Net Change In Cash | -2.68M | -1.28M | 7.66M | 1.47M | 94K | -10.23M | -37.08M | -36.49M | 86.61M | 295K |
Cash at end of period | 9.44M | 12.12M | 13.41M | 5.74M | 4.27M | 4.18M | 14.42M | 51.50M | 88.00M | 1.38M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |